RhumbLine Advisers’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.29M | Sell |
|
|||||
|
2025
Q2 | $5.53M | Buy |
|
|||||
|
2025
Q1 | $4.54M | Buy |
|
|||||
|
2024
Q4 | $4.63M | Buy |
|
|||||
|
2024
Q3 | $4.23M | Sell |
|
|||||
|
2024
Q2 | $3.41M | Buy |
|
|||||
|
2024
Q1 | $3.32M | Buy |
|
|||||
|
2023
Q4 | $3.36M | Sell |
|
|||||
|
2023
Q3 | $1.68M | Buy |
|
|||||
|
2023
Q2 | $1.15M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $656K | Sell |
|
|||||
|
2021
Q4 | $604K | Sell |
|
|||||
|
2021
Q3 | $800K | Buy |
|
|||||
|
2021
Q2 | $1.2M | Buy |
|
|||||
|
2021
Q1 | $854K | Sell |
|
|||||
|
2020
Q4 | $1.24M | Buy |
|
|||||
|
2020
Q3 | $839K | Sell |
|
|||||
|
2020
Q2 | $995K | Buy |
|
|||||
|
2020
Q1 | $525K | Buy |
|
|||||
|
2019
Q4 | $744K | Buy |
|
|||||
|
2019
Q3 | $558K | Sell |
|
|||||
|
2019
Q2 | $574K | Buy |
|
|||||
|
2019
Q1 | $537K | Buy |
|
|||||
|
2018
Q4 | $526K | Buy |
|
|||||
|
2018
Q3 | $353K | Buy |
|
|||||
|
2018
Q2 | $357K | Buy |
|